Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
Saved in:
| Title: | Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. |
|---|---|
| Authors: | Sim WC; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee W; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Sim H; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee KY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Jung SH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Choi YJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kim HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee JY; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Choi YJ; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Kim SK; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Jun DW; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea., Kim W; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Lee BH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Electronic address: lee@snu.ac.kr. |
| Source: | Metabolism: clinical and experimental [Metabolism] 2020 Jan; Vol. 102, pp. 154000. Date of Electronic Publication: 2019 Oct 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0375267 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8600 (Electronic) Linking ISSN: 00260495 NLM ISO Abbreviation: Metabolism Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
